# MEdical Treatment in Idiopathic Ventricular Fibrillation Patients

Study · id `cardio:ct-nct07405229` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07405229](<https://clinicaltrials.gov/study/NCT07405229>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07405229

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 218 participants.

## Technical summary

Registry record NCT07405229. Randomized; single masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2032-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 218 participants (planned count; ClinicalTrials.gov record NCT07405229, source copy `cardio:ctgov-nct07405229-2026-09-01`, retrieved 2026-10-26)
- Started: 2018-05-01 (actual) (ClinicalTrials.gov record NCT07405229, source copy `cardio:ctgov-nct07405229-2026-09-01`, retrieved 2026-10-26)
- Primary completion: 2032-12-31 (anticipated) (ClinicalTrials.gov record NCT07405229, source copy `cardio:ctgov-nct07405229-2026-09-01`, retrieved 2026-10-26)
- Completion: 2035-12-31 (anticipated) (ClinicalTrials.gov record NCT07405229, source copy `cardio:ctgov-nct07405229-2026-09-01`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT07405229, source copy `cardio:ctgov-nct07405229-2026-09-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07405229-2026-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
- Acronym: RIME-IVF
- Condition: Idiopathic Ventricular Fibrillation
- Condition: Cardiac Arrest, Out-Of-Hospital
- Intervention (Drug): Beta-blocker treatment group
- Lead sponsor: Bo Gregers Winkel
- Lead sponsor class: OTHER
- Collaborator: Novo Nordisk Foundation
- Collaborator class: OTHER
- Collaborator: Danish Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as a collaborator: Danish Heart Foundation (`cardio:org-danish-heart-foundation`)

## Provenance

Content hash: 14f5aba98cd4a624d5b05208515fa91e6b4eead1019a4a6d435fec735b96337c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
